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Abstract
In lean humans, increasing dietary fat intake causes an increase in whole-body fat oxidation and changes in genes that
regulate fat oxidation in skeletal muscle, but whether this occurs in obese humans is not known. We compared changes in
whole-body fat oxidation and markers of muscle oxidative capacity differ in lean (LN) and obese (OB) adults exposed to a 2-
day high-fat (HF) diet. Ten LN (BMI=22.562.5 kg/m
2, age=3068 yrs) and nine OB (BMI=35.964.93 kg/m
2,3 8 65 yrs,
Mean6SD) were studied in a room calorimeter for 24hr while consuming isocaloric low-fat (LF, 20% of energy) and HF (50%
of energy) diets. A muscle biopsy was obtained the next morning following an overnight fast. 24h respiratory quotient (RQ)
did not significantly differ between groups (LN: 0.9160.01; OB: 0.9260.01) during LF, and similarly decreased during HF in
LN (0.8660.01) and OB (0.8560.01). The expression of pyruvate dehydrogenase kinase 4 (PDK4) and the fatty acid
transporter CD36 increased in both LN and OB during HF. No other changes in mRNA or protein were observed. However, in
both LN and OB, the amounts of acetylated peroxisome proliferator-activated receptor c coactivator-1-a (PGC1-a)
significantly decreased and phosphorylated 5-AMP-activated protein kinase (AMPK) significantly increased. In response to
an isoenergetic increase in dietary fat, whole-body fat oxidation similarly increases in LN and OB, in association with a shift
towards oxidative metabolism in skeletal muscle, suggesting that the ability to adapt to an acute increase in dietary fat is
not impaired in obesity.
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Introduction
Although genetics is a contributing factor [1], the rapid increase
in the prevalence of obesity suggests that environmental factors
increase the risk of obesity in susceptible individuals. One such
environmental factor may be a high intake of dietary fat [2,3,4].
Unlike carbohydrate and protein [5,6,7], when dietary fat intake
increases, fat oxidation slowly increases over several days until
oxidation matches intake [8,9], which in absence of a compen-
satory increase in energy expenditure will result in an increase in
fat mass [10]. Since low rates of fat oxidation are associated with
gains in fat mass over time [11,12], studying the effects of
increased dietary fat intake on fat oxidation and its regulatory
pathways may yield insight into susceptibility to weight gain.
It has been suggested that the ability to adapt to a high fat diet
(HF) is impaired in obese individuals [13,14] but few studies have
directly compared lean and obese humans. Although studying
changes in whole body fat oxidation provides some insight on the
capacity to respond to changes in nutrient availability, studying
changes at the molecular level in metabolically active tissues such
as skeletal muscle will enhance the understanding of the
pathophysiology of obesity. Studies in non-obese humans have
demonstrated that increasing fat intake increases the expression,
translation, and activity of several mediators of fat uptake and
oxidation in skeletal muscle such as lipoprotein lipase (LPL) [15],
the fatty acid transporter CD36 [16], and pyruvate dehydrogenase
kinase 4 (PDK4) [16,17,18,19,20]. Collectively, these results
suggest that in metabolically healthy individuals, increasing fat
intake induces changes in skeletal muscle that increases fat
oxidation and reduces carbohydrate oxidation. Skeletal muscle
oxidative capacity is regulated by the complex interaction between
5-AMP-activated protein kinase (AMPK), silent mating type
information regulation 2 homolog 1 (SIRT1) [21,22,23], and
peroxisome proliferator-activated receptor c coactivator-1-a
(PGC1-a) [24,25,26]. AMPK and SIRT1 are intracellular fuel
sensors that respond to changes in nutrient and energy availability
[27]. PGC1- a is a nuclear encoded protein that is activated by
AMPK and SIRT1 [28], and coactivates transcription factors and
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3,5 2nuclear receptors that control cell function, including the
expression of genes involved in fatty acid oxidation [25]. How
increasing fat intake affects this network in skeletal muscle is not
completely understood. Although studies in rodent models have
shown increases in SIRT1, AMPK, and PGC1- a mRNA and
protein in response to high fatty acid loads [29,30,31,32], a study
in lean humans reported a decrease in the mRNA of PGC1- a and
other genes associated with oxidative capacity in response to an
increase in dietary fat intake [33]. To our knowledge, only one
study has compared the molecular adaptations to a HF diet in lean
and obese humans [34]. In that study, the expression of PDK4 and
PGC1- a increased in lean but decreased in the obese subjects,
suggesting an impaired adaptation in the muscle of the obese
subjects. The extent that these effects lead to changes in protein
levels of these genes or in whole body substrate oxidation has not
been investigated.
The purpose of this study was to test the hypothesis that obese,
non-diabetic humans have an impaired ability to adapt to a HF
diet. To do so, we compared changes in 24h fat oxidation and
changes in gene expression, protein content, and post-transcrip-
tional regulation of proteins regulating fat metabolism in muscle in
lean and obese individuals in response to an increase in dietary fat
intake.
Methods
Institutional Approval
The study was approved by the Colorado Multiple Institutional
Review Board (COMIRB) and the Scientific Advisory Board of
the Clinical Translation Research Center (CTRC) at the
University of Colorado-Denver (UCD). Informed written consent
was obtained from each subject. Subject recruitment began in
January, 2007, and subjects were studied between February, 2007
and March, 2009.
Subjects
Healthy lean (LN, body mass index (BMI) =19–25 kg/m
2), and
obese (OB, BMI =30–40 kg/m
2) adults (20–45 years) were
recruited for this study. Respondents were queried about their age,
current and past body weight, physical activity patterns, and
health history during an initial telephone screening. Inclusion
criteria were self-reported weight stability (less than 5% change in
body weight over the previous 6 months), a sedentary lifestyle (,1
exercise bout/week and sporting activities ,1 hr/wk) and no
history of prior obesity in lean subjects. Additional exclusion
criteria for female volunteers were pregnancy or lactation,
amenorrhea (absence of three or more consecutive menstrual
cycles), self-reported abnormal menstrual cycle length (,26 days
or .32 days), and post-menopausal status. Screening procedures
confirmed that volunteers were healthy and non-diabetic [35].
Volunteers who passed the initial screening provided informed
written consent, and were then invited to participate in a health
history and physical examination. BMI was confirmed by
measuring height and weight while wearing only socks, undergar-
ments, and a hospital gown. After acceptance into the study,
resting metabolic rate and body composition were measured, as
described previously [35]. The characteristics of the 19 subjects
included in this study are presented in Table 1. As expected,
weight, BMI, and percent body fat were higher in OB than in LN
(P,0.05).
Study design
This study was conducted as part of a larger study of the effects
of exercise (EX) and HF diets on substrate oxidation [35]. Subjects
completed three trials, each separated by 1–3 weeks. The first trial
served as the low fat control condition (LF), which was performed
first to confirm that energy balance was achieved during the
calorimeter stay. Subjects then performed either the EX or HF
diet conditions in random order. Only data from the LF and HF
conditions are presented here. Each condition lasted four days;
subjects consumed a controlled outpatient diet on days 1–3 (to
stabilize energy and macronutrient intake), and were studied in the
room calorimeter on day 4. During the LF condition, subjects
consumed the LF diet on days 1–4. During the HF diet condition,
subjects consumed the LF diet for days 1–2, and then switched to a
HF diet on days 3–4. Thus, the calorimeter measurements were
obtained 24–48 hrs after the increase in dietary fat intake. We
purposely chose this time frame based on our review of previous
studies. Although complete adaptation to an isocaloric HF diet
may take upwards of 7 days [8], a rapid and dramatic shift in
substrate oxidation occurs within the first 24–48 hrs in both lean
and obese subjects, as has been demonstrated in several studies
[36,37,38]. Moreover, the magnitude to change in substrate
oxidation is most pronounced within this first 24–48 hrs. Subjects
were provided all meals during the four day trials. Subjects were
instructed to maintain their typical sedentary lifestyle during the
outpatient phase.
Study diets
Study diets were prepared using individual food preferences.
Prior to the study, subjects completed a survey indicating types of
foods they liked and disliked. Meals consisted primarily of whole
foods, and the increase in dietary fat content was achieved
primarily by substituting lower fat items (e.g. low fat cheese, milk,
and yogurt) with higher fat versions. The LF and HF diets were
matched for energy and protein content, but varied in the amount
of fat (20% and 50%, respectively) and carbohydrate (65% and
35%, respectively). The diets had a similar proportion of mono-,
poly, and saturated fats (as a percentage of fat calories). The LF
diet was comprised of 8–12% mono-unsaturated fat (as a percent
of total calories), 3–5% polyunsaturated, and no more than 6%
saturated fat. The HF diet was comprised of 20–30% mono-
unsaturated fats, 8–12% polyunsaturated fats, and no more than
16% saturated fat. All diets were designed by a trained nutritionist
using ProNutra software (Viocare Nic, Princeton, NJ). The energy
content of the diets was estimated to maintain energy balance, as
described previously [39]. Meals were packaged and taken with
the subject. All food was required to be consumed, and no other
food was permitted. Two optional food modules (200 kcal each)
were provided in the event that the subject experienced hunger.
To verify compliance to the diets, subjects were required to return
the empty food containers to the study personnel.
Calorimeter protocol
Subjects entered the calorimeter at 0800 hrs and exited at 0700
hrs the following day. Three bouts of bench-stepping exercise
(3620 minutes at 72 steps/min) were performed each day at 0830,
1350, and 1850 to mimic free-living physical activity. Subjects
were free to move about the calorimeter during other times of the
day, but primarily this time was spent in sedentary behavior
(reading, writing, computer use, watching TV). Subjects were
instructed to remain awake and not to nap or perform any exercise
other than that prescribed by the protocol, and to go to bed at the
same time during each calorimeter stay. Subjects recorded their
time to bed, and all subjects reported going to bed prior to 2300
hrs. Meals were provided at 0900, 1315, and 1730 hrs, and a light
snack was provided at 2000 hrs. The distribution of total daily
energy intake was 30% at each meal and 10% in the evening
Adaptation to High Fat Diets
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30164snack. Venous blood samples were obtained at several time-points.
Since continuous or frequent blood sampling is not practical in the
room calorimeter, we selected time points to represent fasting
(prior to entry, after exiting the calorimeter) and before and after
meals. To obtain blood samples, subjects extended their arm
through a leak-free port in the calorimeter wall. Subjects exited the
room at 0700 the following morning, at which time a muscle
biopsy was obtained.
24 h EE and substrate oxidation
Calorimeter data were extrapolated to 24h values, based on
average minute values. 24h energy expenditure (EE) and total
substrate oxidation were determined from oxygen consumption
(VO2), carbon dioxide production (VCO2) and nitrogen excretion
in the urines, as previously described [35].
Blood analyses
Whole blood (2.5 mL) was added to a preservative (3.6 mg
EDTA plus 2.4 mg glutathione in distilled water). Serum was
separated after spinning and stored at 280uC until analyzed.
Fasting samples were assayed for glucose, insulin, triglycerides
(TG), and FFA. All the other samples collected during the test
were assayed for FFA and TG. Glucose concentrations were
determined using the hexokinase method (Roche Indianapolis,
IN)). Insulin concentrations were measured using standard, double
antibody radioimmunoassay (Diagnostic Systems Laboratory,
Webster, CT). FFA (Wako Chemical, Richmond, VA) and TG
concentrations (Sigma Diagnostics, St. Louis, MO) were deter-
mined using enzymatic assays.
Skeletal muscle biopsy
Muscle biopsies were obtained upon exiting the calorimeter on
day 5. Subjects were fasted overnight prior to the biopsy.
Subcutaneous tissue overlying the vastus lateralis muscle was
infiltrated with 1% lidocaine. A small incision was made with a
scalpel down through the level of the fascia. A Bergstrom side-cut
biopsy needle with suction was used to remove approximately
0.25g of skeletal muscle tissue. Tissue samples were frozen
immediately using the ‘‘freeze clamp’’ method. The biopsy
samples were stored at 280uC until analyzed.
Gene expression
After total RNA extraction, the relative expression levels of
AMPKa2, CD36, cytochrome oxidase 4 (COX4), a marker of
electron transport activity, PDK4, PGC1-a, LPL, SIRT1 were
analyzed and quantified using the Experion System (Bio-Rad,
Hercules, CA). Reverse transcription was performed using 250 ng
total RNA with iScript cDNA synthesis kit (Bio-Rad). Quantitative
PCR was performed using primer sets for genes of interest and two
reference genes and iQ SYBR Supermix (Bio-Rad) following
manufacturer’s protocol. Reactions were run in duplicate on an
iQ5 Real-Time PCR Detection System (Bio-Rad) along with a no-
template control per gene. RNA expression data were normalized
to levels of reference gene RPL13A and UBC using the
comparative threshold cycle method. To demonstrate that
efficiencies of target and reference genes are approximately equal,
validation experiments were performed.
Immunoblotting
The total amounts of AMPK, PGC1-a, and SIRT1 as well as
phospho-AMPK and acetylated PGC-1a were determined by
immunoblotting with the corresponding specific antibodies. Four
hundred mcg of protein lysate were used to immunoprecipitate
AMPK, PGC1-a, and SIRT1. PGC1- a lysine acetylation was
analyzed by immunoprecipitation of PGC1- a followed by Western
blot using acetyl-lysine antibodies (Cell Signaling Technologies,
Danvers, MA, USA) as previously described [40]. Bovine serum
albumin (BSA) and the protease inhibitors aprotinin and leupeptin
were purchased from Boehringer Mannheim (Indianapolis, IN,
USA). Protein Agarose beads, PGC1-a polyclonal antibody,
AMPKa1/2 monocloanal antibody (#sc74461) and phospho-
AMPK –Thr 172 antibodies as well as SIRT1 polyclonal antibody
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA, and anti-mouse and anti-rabbit HRP labeled antibodies were
Table 1. Subject characteristics.
All subjects Subjects with muscle biopsies
Lean Obese Lean Obese
n1 0 9 5 6
Sex 6F/4M 4F/5M 1F/4M 4F/2M
Age 30683 7 673 1 610 3867
BMI (kg/m2) 22.562.1 35.364.3* 22.962.5 35.164.1*
waist circumference (cm) 78.367.4 107.9616.4* 82.767.0 111.0614.5*
Weight (kg) 66.767.6 111.0622.7* 71.266.5 106.1617.1*
Fat-free mass (kg) 48.967.7 63.9611.4* 54.167.6 62.269.6
Fat mass (kg) 17.664.6 42.268.9* 17.065.4 43.568.1*
% Fat mass (%) 26.666.5 39.563.3* 24.067.8 41.163.1*
Fasting insulin (mUI/l) 9.462.7 18.368.6* 11.061.7 18.769.2
Fasting glucose (mg/dl) 79.3612.7 85.867.7 90.067.2 83.568.3
HOMA-IR 1.8960.73 3.8761.86* 2.4560.46 3.8161.87
Fasting cholesterol (mg/dl) 155.9618.2 163.4634.9 147.4621.4 178.3631.3
Fasting triglycerides (mg/dl) 88.7625.1 142.9677.7* 100.2630.8 164.3688.0
All values are mean6SD.
*P,0.05 versus Lean group.
doi:10.1371/journal.pone.0030164.t001
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and kits were obtaeind from BioRad Laboratories (Hercules, CA,
USA).and GE Healthcare Bio Science/Amersham Biosciences
(Piscataway, NJ, USA).
Statistical Analysis
Statistical analyses were carried out using Graphpad Prism
(Version 5.03, La Jolla, CA). To determine the effect of HF diet on
24 h substrate oxidation, substrate balance, and FFA and TG
AUC, analyses used repeated measures ANOVA to account for
repeated measurements on subjects during two conditions (LF diet
versus HF diet) with group (LN versus OB) as main effect. For
significant interactions, Tukey’s post-hoc tests were performed to
determine within group differences between conditions. If the
interaction terms were non-significant, then the main effects of
group and condition were evaluated. The effects of study diets on
molecular adaptations at muscle level were also analyzed using
repeated measures ANOVA. Significance for all tests was set at
P=0.05. Data are presented as Mean6SEM unless otherwise
specified.
Results
Energy expenditure and energy balance
Absolute EE was significantly higher in OB compared to LN,
but when expressed relative to FFM, there were no differences
between groups (Table 2). 24 h EE did not differ between the LF
and HF conditions in either LN or OB. Mean energy balance for
each group was close to zero (,685 kcal/day for each group and
condition; Table 2), and did not differ between groups or
conditions.
Twenty four hour substrate oxidation and balance
During LF diet, 24 h RQ did not significantly differ between
groups (Table 2). After two days on the HF diet, twenty-four hour
RQ was significantly reduced in both groups, but not different
between LN (0.8460.01) and OB (0.8360.01). Absolute protein,
carbohydrate and fat oxidation (g/day) were higher in OB than in
LN (Table 2), but there was no between-group differences when
expressed relative to FFM (g/kg FFM/24 h) (Figure 1). Twenty
four hour protein oxidation did not differ on the LF and HF diets.
However, 24 h fat carbohydrate oxidation was significantly lower
and 24 h fat oxidation was significantly higher during HF
(P,0.001) in both groups (Table 2, Figure 1). Twenty four hour
protein balance (Figure 2) was slightly positive and did not differ
on the LF and HF diets. In both groups, 24 h carbohydrate
balance (Figure 2) was significantly lower (288620, and
2187650 g/day in LN, and OB, respectively) and 24 h fat
balance (Figure 2) was significantly higher (+4366, and
+34617 g/day in LN and OB, respectively) during HF compared
to LF. The change in fat balance between LF and HF was not
significantly different between LN and OB (P=0.65, 95% CI
=248.3 to +31.1 g/day).
Twenty four hour plasma FFA and triglycerides kinetics
To assess the overall effect of diet and obesity on FFA and TG
concentrations, we calculated the area under the curve (AUC) of
FFA and TG concentrations over 24hr (Figure 3). FFA AUC was
significantly higher during HF in both LN and OB. The significant
interaction (P=0.04) suggests that the increase was greater in OB
than LN. Although post-hoc analyses of the 24 h FFA profiles
indicated some differences in FFA between LN and OB at
different time points, the magnitude of these differences were
small. TG AUC was significantly lower during HF in both LN and
OB (P=0.003), but not different between LN and OB (P=0.07),
Post-hoc analysis of the 24 h TG profiles indicated some
differences in TG between LN and OB, particularly during the
post-prandial period during the HF diet.
Muscle gene expression
An insufficient quantity of muscle was obtained from the biopsy
of several subjects; thus, the muscle analyses are based on samples
Table 2. Room calorimeter results (mean6SE).
Lean
(LN)
Obese
(OB)
N=10 N=9
ANOVA
P-value
LF HF LF HF Group Condition Interaction
24 h Energy expenditure
kcal/day
1 2217683 2161688 31806180 31336180 ,0.0001 ns ns
kcal/kg FFM/day 45.761.2 46.660.8 44.561.2 45.960.8 ns ns ns
Energy balance (kcal/day) 42641 84648 250640 233675 ns ns ns
Physical Activity Level (PAL)
4 1.6160.05 1.56 60.08 1.5760.08 1.5560.06 ns ns ns
24 h RQ
2 0.9060.01 0.8460.01 0.9060.01 0.8360.01 ns ,0.0001 ns
Protein oxidation (g)
1 72667 7 68 10169 10566 ,0.05 ns ns
Carbohydrate oxidation (g)
1,2 344624 256620 507653 320640 ,0.05 ,0.0001 ns
Fat oxidation (g)
1,3 49699 2 610 67610 140615 ,0.05 ,0.0001 ns
1OB . LN.
2LF . HF.
3LF , HF.
4PAL =24 h EE/resting metabolic rate.
RQ=respiratory quotient.
FFM=fat free mass.
FM=fat free mass.
doi:10.1371/journal.pone.0030164.t002
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males) subjects. There were no differences in expression of AMPK,
COX4, LPL, PGC1-a and SIRT1 in LN and OB. However,
mRNA CD36 and PDK4 levels were higher in OB than in LN
(P,0.01 for both). Increasing dietary fat intake did not change the
expression of AMPK, COX4, LPL, PGC1-a or SIRT1 in either
group (Table 3). However, increasing dietary fat intake signifi-
cantly increased the expression of CD36 and PDK4 in both LN
and OB. The increase in PDK4 mRNA was however more
pronounced in OB than in LN subjects (P for interaction ,0.01).
Muscle protein content and post-transcriptional
regulation
The amount of SIRT1 protein in skeletal muscle did not differ
between the HF or LF dietary conditions in both groups (data not
shown). However, the significantly lower amount of acetylated
PGC1-a during the HF diet (P,0.001, Figure 4, Bottom) coupled
with no change in total PGC1-a protein (Figure 4, Top) suggests
that the deacetylating activity of SIRT1 was markedly enhanced
by the HF diet. Although the total amount of AMPK was not
affected by the diet (Figure 5, Top), the HF diet significantly
increased the phosphorylation of AMPK in both LN and OB
(Figure 5, Bottom).
Discussion
Several studies have examined the effects of obesity on the
ability to adapt to a HF diet [14,36,37], but few have actually
compared obese and lean subjects. Two of these studies reported
that when overfed a HF diet (resulting in positive energy balance),
obese subjects had an impaired ability to increase fat oxidation
[13,14]. In the current study, although an isocaloric increase in
dietary fat intake from 20% to 50% resulted in positive 24h fat
balance in both LN and OB, the change in carbohydrate and fat
oxidation and thus, the resulting fat balance, were similar.
Moreover, changes in markers of skeletal muscle oxidative
capacity were remarkably similar. Although no changes in
PGC1-a, SIRT1, or AMPK mRNA or protein were observed,
the amount of de-acetylated PGC1-a and pAMPK were increased
in both LN and OB indicating an increase in the activity of both
SIRT1 and AMPK respectively. The fact that 24hr fat oxidation
and muscle oxidative capacity were not different in LN and OB
groups in response to HF suggests that uptake by skeletal muscle
was similar in LN and OB. Collectively, these results suggest that
the ability to increase fat oxidation in response to an acute
isocaloric increase in dietary fat intake is preserved in obese, non-
diabetic humans at both the whole body and skeletal muscle level.
Although the observed increase in whole body fat oxidation is
consistent with previous studies in humans [8,9,36,41] the novel
finding of the current study is that in obese, the ability to adapt to
the increase in dietary fat intake is preserved, at least during
isocaloric conditions. We also present novel findings regarding the
effects on important cellular signaling molecules that regulate fat
oxidation in skeletal muscle. An increase in dietary fat intake from
20% to 50% of total calories for two days induced significant
changes in SIRT1 and AMPK activity, without changing the
expression or translation of these proteins. There were also no
Figure 1. Mean (± SE) Protein (Top), carbohydrate (Middle),
and fat (Bottom) oxidation (g/kg FFM/day) measured using
room calorimetry during LF (black bars) and HF (grey bars) in
LN (N=10) and OB (N=9). * LF significantly different from HF
(P,0.05).
doi:10.1371/journal.pone.0030164.g001
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may be largely determined by post-translational modifications
[28,30,40], as indicated by the change in acetylated PGC1-a
observed in the current study. These results suggest that in
humans, increasing fat intake for two days leads to changes in
skeletal muscle that would be expected to increase oxidative
capacity. These findings are consistent with studies in mice that
have shown that raising serum FFA by feeding them HF diets [32]
or combining HF diets with daily heparin injections [31] leads to a
gradual increase in skeletal muscle PGC1-a protein and
mitochondrial proteins over several weeks, suggesting that
oxidative capacity is increased. It is likely that the relatively short
exposure to the HF diet in the current study was not sufficient to
induce changes in mRNA or protein of PGC1-a or SIRT1, as seen
in the longer studies in mice.
Changes in FFA and TG in response to the HF diets were
similar in LN and OB, i.e. FFA increased and TG decreased. The
decrease in TG during HF diet is likely due to a decrease in
carbohydrate availability, as has been previously been reported
[42,43,44]. Although a significant difference in FFA AUC was
observed, the magnitude of differences between LN and OB on
both the LF and HF diets was small. We would contend that the
physiological significance of such small differences is dubious. It is
possible that these small differences were due to the study design,
i.e., isocaloric LF and HF diets, and that larger differences would
have been observed under conditions of energy surplus. None-
theless, we concede that the small differences in the current study
may conceal some underlying differences in FFA trafficking. It is
possible that the higher TG concentrations in OB than LN,
particularly during the post-prandial period, is related to the
slightly higher plasma FFA concentrations in OB, since FFA is the
main source for VLDL-TG synthesis [45]. Our findings that
circulating FFA concentrations are slightly elevated in obese
individuals is consistent with the observation by Karpe et al. [46]
that although lipolysis and FFA delivery under fasting conditions is
downregulated in obesity, an elevation in fasting FFA is observed
in some obese individuals. In these individuals, it is likely that
delivery of FFA to non-adipose tissue is increased. However, how
lipolysis and FFA delivery during HF feeding is regulated in obese
individuals during HF feeding has not been studied, to our
knowledge. In our study, given that whole body fat oxidation did
not differ in LN and OB during either diet condition, and that
skeletal muscle is the primary tissue where fat is oxidized, it is
possible that FFA delivery to other tissues (e.g. adipose tissue, liver)
was increased in OB subjects. However without kinetic measure-
ments, it is not possible to determine if differences in lipid
trafficking contributed to these small differences in circulating FFA
and TG.
The effect of increasing fat intake on molecular markers of fat
oxidation in human skeletal muscle has not been well studied,
and results from previous studies have been equivocal. In lean
humans, increasing fat intake from 35% to 50% of total calories
for three days induced a decrease in PGC1-a mRNA and other
genes associated with oxidative capacity [33]. In a more recent
study, exposure to a high fat diet (65%) for five days increased
PGC1-a mRNA in lean but not obese subjects [34]. Possible
reasons that may have contributed to different results (with
regards to PGC1-a mRNA) of the current study and previous
studies may include different levels of fat intake during the control
and HF diet conditions and different length of exposure to the
HF diets. It is also possible that differences in the types of fat
(mono-, poly, and saturated) could contribute to differences
between studies, but prior studies have not reported the
distribution of fat calories in the experimental diets. It is also
noteworthy that in contrast to our obese subjects, Boyle et al. [34]
studied morbidly obese individuals (BMI.35 kg/m
2). This raises
the possibility that the ability to adapt to a HF diet may depend
upon the level of excess adiposity. This remains an area for future
investigation.
Figure 2. Mean (± SE) 24 h (g/day) protein (Top), carbohydrate
(Middle), and fat (Bottom) balance measured using room
calorimetry during LF (black bars) and HF (grey bars) in LN
(N=10) and OB (N=9). * LF significantly different from HF (P,0.05).
doi:10.1371/journal.pone.0030164.g002
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both AMPK and SIRT1 as an adaptive mechanism to increase
ATP production from fat oxidation [47,48,49,50]. Although the
specific nutrient signals which activate the AMPK/SIRT1/PGC1-
a pathways are not known, it has been speculated that fluctuations
in nutrient supply may serve to synchronize this metabolic
networks [51]. In line with this hypothesis, the results of the
current study suggest that either a decreased availability of dietary
carbohydrate or an excess availability of dietary fat may be one of
the sensors that activate the AMPK/SIRT1/PGC1-a network.
We could not, however, determine the specific intracellular signals
that activated this network. Both SIRT1 and AMPK are activated
by nutrient deprivation [51,52]. AMPK is activated by increases in
cellular AMP content, resulting in phosphorylation and activation
of PGC-1a [53]. SIRT1 is activated by an increase in the cellular
NAD
+/NADH ratio, resulting in deacetylation and activation of
PGC1-a [51,54]. However, we cannot rule out the possibility that
activation occurred via other pathways. For example, it was
recently shown that a HF diet induced increases in NAD
+ in liver
and white adipose tissue, but not muscle [55], suggesting that
NAD
+ activation of SIRT1 may be tissue specific. Additionally, a
recent study in humans demonstrated SIRT1 activity is not
required for exercise-induced deacetylation of PGC1-a in muscle;
deacetylation was induced via a novel acetyltransferase, general
control of amino-acid synthesis-5 [56]. Results of these studies
suggest that activation of PGC1-a activity in muscle is regulated
on multiple levels that are not completely understood at the
present time.
The activation of this network may have contributed to increase
PDK4 gene expression [57], which plays a critical role in the
partitioning of substrate toward either lipid or carbohydrate
oxidation [58]. Although we were unable to assess PDK4 protein
levels, it has been previously shown that HF diet simultaneously
increases PDK4 mRNA and protein levels in lean subjects [16,19].
Furthermore, although the increase in mRNA PDK4 in response
to a HF diet is in accordance with several previous reports in lean
subjects [17,20,34], it is the opposite of what Boyle et al [34]
observed in morbidly obese individuals.
The strengths of this study include carefully targeted levels of
energy balance, and the combined approach of measuring changes
on the whole-body and molecular level. There are several
limitations. Although we purposely studied subjects in energy
balance, differences between groups may be more apparent during
other conditions such as overfeeding, as has been previously
demonstrated in lean vs. obese men [13]. Overfeeding appears to
be necessary for the HF diet induced increase in energy
expenditure and fat oxidation that occurs in obesity-resistant,
but not obesity-prone, rats [59,60]. We also studied subjects under
Figure 3. Plasma FFA (± SE; Left) and triglycerides (± SE; Right) during LF (Top) and HF (Middle) diets in LN (N=10; dashed line),
and OB (N=9; solid line). 24 h FFA and triglycerides areas under the curve (AUC) are presented in the bottom graphs.
doi:10.1371/journal.pone.0030164.g003
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30164controlled physical activity levels. It is well known that exercise
increases fat oxidation, and that a more complete adaptation to an
increase in dietary fat intake occurred when subjects are studied
during high vs. low levels of physical activity (PAL=1.8 vs. 1.4)
[9]. The level of physical activity (PAL=1.6) similar between
groups may have impaired our ability to detect differences
between lean and obese and studies with different levels of activity
during the day of test may be warranted. Additionally, although
the number of subjects in each group is similar or larger than
previously published studies [9,36,37,38,41,61,62], we lacked
sufficient statistical power to determine the effects of sex.
Moreover, adequate muscle samples were available on only a
subset of subjects, and the distribution of males and female
samples differed in the LN and OB groups. However, given the
robust and equal response in PGC1-a and pAMPK in both
groups, it is unlikely that the sex distribution affected our results.
We also lacked adequate samples to perform analyses of
downstream or upstream markers of PGC1-a and SIRT1 activity
such as changes in acetyl CoA carboxylase and NAD/NADH
ratio, respectively. Finally, the length of the dietary intervention
was very short. The changes induced by long-term exposure to
excess dietary fat remain unknown. Performing such studies would
enhance our knowledge of the mechanisms by which skeletal
muscle regulates fatty acid oxidation, and would contribute to our
understanding of the association between the pathophysiology of
metabolic diseases.
In summary, results of this study demonstrate that increasing
dietary fat intake increases whole-body fat oxidation, and this is
accompanied by changes in skeletal muscle that reflect a shift
towards oxidative metabolism. The response is similar in lean and
obese individuals, suggesting that the ability to adapt to an acute
increase in dietary fat is not impaired in obesity. We cannot rule
out, however, that differences may have existed in the OB subjects
prior to them becoming obese, and this is what contributed to the
development of obesity in the first place. At the molecular level,
substantial increases in the activity of SIRT1 and AMPK were
observed, without changes in the message or protein. Thus, our
data suggest that changes in skeletal muscle oxidative capacity
cannot be inferred from changes in mRNA or protein expression.
Despite these changes, fat balance was more positive during HF
than LF in both groups, suggesting that HF diets will promote an
increase in fat mass independent of energy intake under sedentary
conditions. The results of the current study and those of Smith
et al. [9] demonstrate that the best way to prevent against excess
fat gain is to maintain daily physical activity and refrain from
excessive consumption of dietary fat.
Table 3. mRNA results (au, mean6SE).
Lean (LN) Obese (OB)
N=5 N=6 ANOVA P-value
LF HF LF HF Group Condition Interaction
AMPK 0.7560.06 0.8160.08 0.6760.05 0.7760.05 ns ns ns
CD36
1,3 0.5660.05 0.6860.10 0.8060.08 1.1460.08 ,0.01 ,0.05 ns
COX4 0.0660.01 0.0760.01 0.0660.01 0.0660.01 ns ns ns
LPL 0.2860.12 0.2860.08 0.2460.06 0.3660.09 ns ns ns
PDK4 0.1660.04 0.2360.03 0.3160.06 0.9360.14 ,0.01 ,0.01 ,0.01
PGC1a 0.6660.08 0.5760.09 0.5460.04 0.6260.04 ns ns ns
SIRT1 0.06660.01 0.0860.01 0.0660.01 0.0860.01 ns ns ns
1OB . LN.
2LF . HF.
3LF , HF.
doi:10.1371/journal.pone.0030164.t003
Figure 4. Mean (± SE) total (Top) and acetylated (Bottom)
PGC1a protein (Bottom) during LF (black bars) and HF (grey
bars) in LN (N=5) and OB (N=6). Representative blots are show
above the graphs. * LF significantly different from HF (P,0.05).
doi:10.1371/journal.pone.0030164.g004
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